EU funding for arthritis research
As part of the European SQUEEZE collaboration, REMEDY receives 13 million to investigate therapeutic drug monitoring.
- Research
- WP1: Optimized medical interventions
- WP2: Phenotyping for personalized medicine
- WP3: Pain mechanisms and management
- WP4: Managing comorbidities
- WP5: Innovative approaches to remote care
- WP6: Dechiphering long-term outcomes
- WP7: Empowering the individual
- Clinical trial unit
- Program for young researchers
- RECONNECT
- REVMABOOK
- About REMEDY
- National clinical network
- Publications
- Project portfolio
- News
